[1]张 珊,张 伟,李秀华,等.合生素补充联合生活方式干预对非酒精性脂肪肝病人肝硬化和 免疫相关指标的影响[J].肠外与肠内营养杂志,2019,(05):286-291.[doi:DOI : 10.16151/j.1007-810x.2019.05.007]
　ZHANG Shan,ZHANG Wei,LI Xiu-hua,et al.Effect of synbiotic supplementary combined with lifestyle intervention on liver cirrhosis and immune related indexes in nonalcoholic fatty liver disease[J].PARENTERAL & ENTERAL NUTRITION,2019,(05):286-291.[doi:DOI : 10.16151/j.1007-810x.2019.05.007]
点击复制

合生素补充联合生活方式干预对非酒精性脂肪肝病人肝硬化和 免疫相关指标的影响
分享到：

《肠外与肠内营养》杂志[ISSN:1007-810X/CN:32-1477/R]

卷:
期数:
2019年05期
页码:
286-291
栏目:
论著
出版日期:
2019-09-10

文章信息/Info

Title:
Effect of synbiotic supplementary combined with lifestyle intervention on liver cirrhosis and immune related indexes in nonalcoholic fatty liver disease
作者:
张 珊 1; 张 伟 1; 李秀华 1; 董 晴 1; 王 芳 2
1.西安交通大学附属三二〇一医院感染科，陕西汉中 723000；2.延安市人民医院感染科，陕西延安 716000
Author(s):
ZHANG Shan1; ZHANG Wei1;  LI Xiu-hua1;  DONG Qing1;  WANG Fang2
1. Infectious Disease Department, 321 Hospital Affiliated to Xi'an Jiaotong University , Hanzhong 723000, Shaanxi, China；2. Infectious Disease Department, Yan'an People's Hospital, Yanan 716000, Shaanxi, China
关键词:
合生素 ; 非酒精性脂肪肝 ; 生活方式 ; 肝硬化 ; 免疫指标
Keywords:
Synbiotic;  Nonalcoholic fatty liver disease;  Lifestyle;  Liver cirrhosis;  Immune indexes
分类号:
R657.3+1
DOI:
DOI : 10.16151/j.1007-810x.2019.05.007
文献标志码:
A
摘要:
目的：评估补充合生素对 NAFLD病人肝纤维化、肝酶和炎症标志物的影响。 方法：通过随机、双盲、安慰剂对照的临床试验，对 86 例 NAFLD 病人进行初步研究，提供合生素或安慰剂胶囊，周期 28 周，每日两 次。 结果：结果表明，丙氨酸氨基转移酶(ALT)在两组中浓度均降低，且在合生素组更显著。在合生素组和安慰 剂组还观察到以下显著差异 ALT[-24.6(-28.5 ~ -22.3) vs -6.7(-8.9 ~ -4.6) IU/L，P < 0.001]，天冬氨酸转氨酶[-28.4(-31.5 ~ -25.4) vs -5.7(-9.5 ~ -3.1) IU/L，P < 0.001]，γ-谷氨酰转移酶[-12.95(-13.27 ~ -12.82) vs -4.35(-5.17 ~ -3.95) IU/L，P < 0.001]，高敏 C反应蛋白[-2.42(-2.9 ~ -1.7) vs -0.98(-1.34 ~ -0.71) mmol/L，P < 0.005），肿瘤坏死因子-α[-1.64(-1.93 ~ -1.26) vs -0.72(-0.91 ~ -0.43) mmol/L，P < 0.001]，总核因子 κ-B p65[-0.023(-0.031 ~ -0.016) vs -0.003(-0.006 ~ -0.001) mmol/L，P < 0.001），瞬时弹性成像评价纤维化[-2.76（-3.22 ~ -2.18）vs -0.65（-1.16 ~ -0.35）kPa，P < 0.001]。结论：对 NAFLD病人进行生活方式干预联合补充合生素优于单纯改善生活方式，作用机制可能是通过减弱体内炎 症标志物来实现的。这些影响能否持续较长治疗时间仍有待确定。
Abstract:
Objective: To evaluate the effects of supplementation of synbiotics on liver fibrosis, liver enzymes and inflammatory markers in the patients with NAFLD. Methods: A randomized, double-blind, placebo-controlled clinical trial was performed in 86 patients with NAFLD who were supplemented a synbiotic or placebo capsule for 28 weeks, twice daily. Results: The results showed that alanine aminotransferase (ALT) decreased in both groups and was more significant in the synbiotic group. The following significant differences were observed between the synbiotic group and placebo group ALT [-24.6 (-28.5 ~ -22.3) vs -6.7 (-8.9 ~ -4.6) IU/L, P < 0.001], aspartate aminotransferase [-28.4 (-31.5 ~ -25.4) vs -5.7 (-9.5 ~ -3.1) IU/L, P < 0.001], γ-glutamyltransferase[-12.95 (-13.27 ~ -12.82) ) vs -4.35 (-5.17, -3.95) IU/L, P < 0.001], high-sensitivity C-reactive protein [-2.42 (-2.9 ~ -1.7) vs -0.98 (-1.34 ~ -0.71) mmol/L, P <0.005], tumor necrosis factor-α [-1.64 (-1.93 ~ -1.26) vs -0.72 (-0.91 ~ -0.43) mmol/L, P < 0.001], total nuclear factor κ-B p65 [-0.023 (-0.031) ~ -0.016) vs -0.003 (-0.006 ~ -0.001) mmol/L, P < 0.001], transient elastography to evaluate fibrosis[-2.76 (-3.22 ~ -2.18) vs -0.65 (-1.16 ~ -0.35) kPa , P < 0.001]. Conclusions: Lifestyle intervention with NAFLD combined with supplementation of synbiotics is superior to simple lifestyle improvement, and the mechanism may be achieved by attenuating inflammatory markers in vivo. Whether these effects can last longer is still to be determined.

参考文献/References:


[1] 吴雏燕, 江钟立, 贺丹军, 等 . 非酒精性脂肪肝患者的生活方式特征研究 . 中国康复医学杂志, 2008, 23(5):398-401.
[2] 卢艳姻, 李子俊 . 非酒精性脂肪性肝病是肠道微生物惹的祸吗?. 肝博士, 2014(3):18-20.
[3] Yang L , Seki E . Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms. Front Physiol, 2012, 3:138.
[4] Miele L , Valenza V , La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology, 2009, 49(6): 1877-1887.
[5] Tilg H , Hotamisligil GS . Nonalcoholic fatty liver disease:Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology, 2006, 131(3):934-945.
[6] 郭士浩 . 大肠杆菌 Nissle1917与肠屏障功能的研究进展 . 肠外与肠内营养, 2018(3):184-187,192.
[7] Ainsworth BE , Haskell WL , Whitt MC , et al. Compendium of Physical Activities: an Update of Activity Codes and MET Intensities. Med Sci Sports Exerc, 2000, 32(9 Suppl):498-504.
[8] Iacono A , Raso GM , Canani RB , et al. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem, 2011, 22(8):699-711.
[9] Larter CZ , Farrell GC . Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?. J Hepatol, 2006, 44 (2):253-261.
[10] Nardone G , Compare D , Liguori E , et al. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. Am J Physiol Gastrointest Liver Physiol, 2010, 299(3):G669-G676.
[11] Li Z , Yang S , Lin H , et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology, 2003, 37(2):343-350.
[12] Malaguarnera M , Vacante M , Antic T , et al. Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis. Dig Dis Sci, 2012, 57(2):545-553.
[13] Ma X , Hua J , Li Z . Probiotics Improve High Fat Diet-induced Hepatic Steatosis and Insulin Resistance by Increasing Hepatic NKT cells. J Hepatol, 2008, 49(5):821-830.
[14] Al-Attas OS , Al-Daghri NM , Al-Rubeaan K , et al. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies.Cardiovasc Diabetol, 2009, 8:20.
[15] Compare D , Coccoli P , Rocco A , et al. Gut– liver axis: The impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis, 2012, 22(6):471-476.
[16] Abenavoli L , Beaugrand M . Transient elastography in non-alco‐holic fatty liver disease. Ann Hepatol, 2012, 11(2):172-178.

备注/Memo

备注/Memo:
作者简介 ：张 珊，主管护师，医学本科，从事感染科病人的营养学研究。E-mall:zhang855shan@163.com 通讯作者 ：王 芳，E-mall:f808shan@163.com
更新日期/Last Update: 1900-01-01